Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 3
- Pharmaceutical
Ireland’s Dunbar Pharma Expands UK Dronabinol Range with Oral Spray
Irish active-ingredient manufacturer Dunbar Pharmaceuticals has launched the UK’s first plant-derived dronabinol oral spray, extending a pharma-grade THC line that reached specialist prescribers in capsule form in August.
- US & Canada
Opponents Filibuster Cannabis Rescheduling With Federal Watchdog Report
As the US cannabis industry eagerly awaits the judge’s final recommendation on whether to extend rescheduling, the next phase has already found itself caught in the weeds of bureaucracy.
- Medical Cannabis
Medical Cannabis Pioneer Bedrocan Fights to Avoid Bankruptcy in Home Market
Bedrocan, the Dutch medical cannabis stalwart thousands of patients rely on for their prescriptions, is now fighting to avoid collapse.
- Adult-Use
Switzerland’s SCRIPT Trial Finds Regulated Cannabis Sales Change How People Consume, Not How Much
Government-led scientific studies from across Europe’s most progressive cannabis markets are solidifying an evidence base suggesting that greater access does not cause greater harm to public health.
- UK & Europe
The Netherlands’ Landmark Adult-Use Cannabis Experiment Publishes First Results
Initial findings from the Netherlands’ landmark ‘controlled cannabis supply chain experiment’ were submitted to the House of Representatives on September 9, the first published findings since the T0 baseline report, published in March 2024 (covering data collected in 2022).
- Medical Cannabis
Overdue ACMD Report Gets New Deadline as Industry Weighs In
By Ben Stevens, with additional reporting by Nicole Farah, Managing Director of Americana Communications.
- CBD Market
Chair of UK’s FSA Says Future of CBD Regulation Will ‘Lie With EU Authorisations’
The long-term future of Britain’s CBD sector ‘really will lie with EU authorisations’, the chair of the Food Standards Agency (FSA) has told its board, a candid admission that the domestic regime the industry has chased for six years may ultimately be superseded by Brussels.
- Cultivation
Are US Cannabis Contracts Enforceable? A $32m Court Ruling Just Said No
A Michigan breach-of-contract dispute between cultivator Hello Farms and Curaleaf Holdings has cracked open a fault line that runs beneath every cannabis contract in the US, opening the door to a ‘mutually assured destruction’ defence that cannot be closed.
- M&A Activity
Organigram – Sanity Group Deal: What Changed and What it Means for Germany
This article was originally published in February 2026, and was most recently updated on September 22, 2026.
- Cultivation
France’s PGP Farmer Selects 5 Cannabis Strains for Future French Production as Market Nears Rollout
PGP Farmer, the French biotech building the country’s first EU-GMP medical cannabis production site, has narrowed a 30-variety Dutch phenotyping trial to five elite cultivars, laying the agronomic groundwork for its 9-hectare Dordogne facility as France closes on the reforms needed for full medical cannabis rollout.
- Medical Cannabis
UK Medical Cannabis Under Review: Where is the ACMD Report?
Pressure is piling on the UK’s Advisory Council on the Misuse of Drugs (ACMD) to publish its highly anticipated review of the country’s medical cannabis framework.
- Cultivation
Inside Northern Leaf’s Remarkable Turnaround: From Brink of Collapse to £8m Cultivator
Northern Leaf, the Jersey-based medical cannabis cultivator, looked all but certain to follow in the footsteps of Curaleaf, Aurora and Tilray to become the British Isles’ very own international cannabis superstar.
